下一代基于抗体的癌症治疗:抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用 Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors PubMed 2026/09/09 发表J Hematol OncolQ1 · IF 47.8(JCR 2025) 靶点:CD19靶点:CD20靶点:BCMA技术:CAR-T技术:双特异性抗体急性淋巴细胞白血病多发性骨髓瘤B细胞淋巴瘤
将 B 细胞与浆细胞靶向从肿瘤学转化至自身免疫:模式、定量桥接与开发路线图 Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap. PubMed 2026/06/05 发表Clin Pharmacol TherQ1 · IF 4.9(JCR 2025) 靶点:CD19靶点:CD20靶点:CD38技术:双特异性抗体淋巴瘤骨髓瘤